Guangdong Fapon Biopharma Inc.
PrivateLast Round
Series B
Dec 31, 2020
Est. Valuation
$1.06B
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Guangdong Fapon Biopharma Inc. operates in Healthcare & Life Sciences and is based in Dongguan. Its latest recorded funding round was a Series B round in December 2020.
Guangdong Fapon Biopharma Inc. is a biotechnology company that specializes in the discovery and development of biologics for the treatment of cancers and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guangdong Fapon Biopharma Inc. Comparables
Compare Guangdong Fapon Biopharma Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EpimAb Biotherapeutics | 81% | |
| Innovent Biologics | 78% | |
| Suzhou Forlong Biotechnology Co., Ltd. | 76% |
For institutional investors. Book with your work email.
Guangdong Fapon Biopharma Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 31, 2020 | ||||
| Early Funding | Jan 1, 2019 | ||||
| Private Placement | May 10, 2017 | ||||
| Private Placement | Aug 18, 2016 |
For institutional investors. Book with your work email.
Guangdong Fapon Biopharma Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | Series B |
| GL Capital Group | Series B |
| Huasheng Capital | Series B |
| Dingfeng Asset Management | Private Placement |
| HongShan Capital Group (HSG) | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 21, 2026
Grew 30% QoQ from 10 to 13 employees.
- May 10, 2017
$1.74M round led by Dingfeng Asset Management
For institutional investors. Book with your work email.
Guangdong Fapon Biopharma Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Guangdong Fapon Biopharma Inc.'s valuation, stock price, and market status.
Is Guangdong Fapon Biopharma Inc. a public or private company?
Guangdong Fapon Biopharma Inc. is a private company.
What is the current stock price of Guangdong Fapon Biopharma Inc.?
Guangdong Fapon Biopharma Inc. is a private company, so its shares have no public market price. Caplight tracks Guangdong Fapon Biopharma Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Guangdong Fapon Biopharma Inc. worth (valuation)?
Guangdong Fapon Biopharma Inc.'s valuation is estimated at $1.1B based on funding round data.
Can I buy Guangdong Fapon Biopharma Inc. stock?
Guangdong Fapon Biopharma Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Guangdong Fapon Biopharma Inc.'s last funding round?
Guangdong Fapon Biopharma Inc.'s most recent funding round was Series B on December 31, 2020.
Who are the main investors in Guangdong Fapon Biopharma Inc.?
Key investors in Guangdong Fapon Biopharma Inc. include Cathay Capital, GL Capital Group, Huasheng Capital, Dingfeng Asset Management, HongShan Capital Group (HSG).
Will Guangdong Fapon Biopharma Inc. IPO soon?
No public IPO plans have been announced for Guangdong Fapon Biopharma Inc..
How can I track Guangdong Fapon Biopharma Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Guangdong Fapon Biopharma Inc.'s shares on secondary markets.